| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DORM | Common Stock | Sale | -$84.4K | -634 | -0.08% | $133.13 | 772K | Jan 30, 2025 | Direct | F1 |
| transaction | DORM | Common Stock | Sale | -$528K | -3.94K | -0.51% | $133.99 | 769K | Jan 30, 2025 | Direct | F2 |
| transaction | DORM | Common Stock | Sale | -$1.09M | -8.1K | -1.05% | $134.95 | 760K | Jan 30, 2025 | Direct | F3 |
| holding | DORM | Common Stock | 100K | Jan 30, 2025 | By trust | F4 | |||||
| holding | DORM | Common Stock | 24.8K | Jan 30, 2025 | By 401(k) | F5 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.355 through $133.350. The reporting person undertakes to provide to Dorman Products, Inc., any security holder of Dorman Products, Inc. or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $133.360 through $134.355. The reporting person undertakes to provide to Dorman Products, Inc., any security holder of Dorman Products, Inc. or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.360 through $135.150. The reporting person undertakes to provide to Dorman Products, Inc., any security holder of Dorman Products, Inc. or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F4 | These shares are held in trust for the benefit of the reporting person's grandchildren. The reporting person's spouse is a co-trustee of the trust. The reporting person disclaims beneficial ownership of the shares held by such trust, and this report should not be deemed an admission that the reporting person is the beneficial owner of the trust's shares for purposes of Section 16 or for any other purpose. |
| F5 | The shares are represented by units held in a unitized stock fund through the Issuer's 401(k) Retirement Plan and Trust. The unitized stock fund of the Issuer's 401(k) Retirement Plan and Trust consists of cash and common stock in amounts that vary from time to time. As of December 31, 2024, the reporting person had 16,343 units in the Issuer's 401(k) Retirement Plan and Trust, which units consisted of 24,769 shares of common stock. |
The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.